Biology of Sleep Substances · 2020 · Book chapter
Explore the library
Insufficient evidenceDelta sleep-inducing nonapeptide
DSIP
DSIP stands for delta sleep-inducing peptide, a nine-amino-acid research peptide also called emideltide. Its historical name describes a research hypothesis, not an established effect on human sleep.
Also indexed as: Delta Sleep Inducing Peptide
A clear starting point
DSIP stands for delta sleep-inducing peptide, a nine-amino-acid research peptide also called emideltide. Its historical name describes a research hypothesis, not an established effect on human sleep.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
Sleep / neuropeptide signaling
DSIP stands for delta sleep-inducing peptide, a nine-amino-acid research peptide also called emideltide. Its historical name describes a research hypothesis, not an established effect on human sleep.
- Targets & processes
- Sleep / neuropeptide signaling
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Historical sleep architecture and stress-response hypotheses.
What this does not establish
A historical book chapter is background literature, not modern independently replicated evidence of insomnia treatment.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
FDA identifies inadequate safety information and possible immunogenicity and impurity risks. Effects with sedatives and other neuroactive drugs are insufficiently characterized.
Contraindications & cautions
Not an exhaustive contraindication review. FDA identifies inadequate safety information and possible immunogenicity and impurity risks. Effects with sedatives and other neuroactive drugs are insufficiently characterized.
Medication & supplement interactions
Interaction information is incomplete. FDA identifies inadequate safety information and possible immunogenicity and impurity risks. Effects with sedatives and other neuroactive drugs are insufficiently characterized.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.